Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer

Background. Adding taxanes to anthracycline-based adjuvant chemotherapy has shown significant improvement particularly in node-positive patients, but optimal dose and schedule remain undetermined. Objectives. This study aimed to assess the feasibility of dose-dense epirubicin and cyclophosphamide fo...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mirzaei, Hamid Reza, Sabet Rasekh, Parisa, Nasrollahi, Fatemeh, Sabet Rasekh, Parto, Akbari Tirabad, Zahra, Moein, Hamid Reza, Ghaffari Pour, Taban, Hajian, Parastoo
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2013
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3800644/
https://ncbi.nlm.nih.gov/pubmed/24187626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/404396
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires